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ABSTRACT
We have previously provided pharmacological evidence that stimulation of calcium-sensing
receptors (CaSR) induces endothelium-dependent relaxations of rabbit mesenteric arteries
through activation of heteromeric TRPV4/TRPC1 channels and nitric oxide (NO) production. The
present study further investigates the role of heteromeric TRPV4/TRPC1 channels in these CaSR-
induced vascular responses by comparing responses in mesenteric arteries from wild-type (WT)
and TRPC1-/- mice. In WT mice, stimulation of CaSR induced endothelium-dependent relaxations
of pre-contracted tone and NO generation in endothelial cells (ECs), which were inhibited by the
TRPV4 channel blocker RN1734 and the TRPC1 blocking antibody T1E3. In addition, TRPV4 and
TRPC1 proteins were colocalised at, or close to, the plasma membrane of endothelial cells (ECs)
from WT mice. In contrast, in TRPC1-/- mice, CaSR-mediated vasorelaxations and NO generation
were greatly reduced, unaffected by T1E3, but blocked by RN1734. In addition, the TRPV4 agonist
GSK1016790A (GSK) induced endothelium-dependent vasorelaxations which were blocked by
RN1734 and T1E3 in WT mice, but only by RN1734 in TRPC1-/- mice. Moreover, GSK activated
cation channel activity with a 6pS conductance in WT ECs but with a 52 pS conductance in
TRPC1-/- ECs. These results indicate that stimulation of CaSR activates heteromeric TRPV4/TRPC1
channels and NO production in ECs, which are responsible for endothelium-dependent vasore-
laxations. This study also suggests that heteromeric TRPV4-TRPC1 channels may form the pre-
dominant TRPV4-containing channels in mouse mesenteric artery ECs. Together, our data further
implicates CaSR-induced pathways and heteromeric TRPV4/TRPC1 channels in the regulation of
vascular tone.
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Introduction
Stimulation of plasmalemmal calcium-sensing recep-
tors (CaSR) by an increase in extracellular Ca2+ con-
centration ([Ca2+]o) is involved in maintaining
plasma Ca2+ homeostasis through regulation of para-
thyroid hormone synthesis and secretion from the
parathyroid gland, intestinal Ca2+ absorption, and
renal Ca2+ excretion [1–3]. It is also apparent that
CaSR are expressed in tissues not associated with
plasma Ca2+ homeostasis, which suggests that CaSR
are likely to be involved in regulating many different
physiological systems.
In the vasculature, functional expression of CaSR in
perivascular nerves, endothelial cells (ECs), and vas-
cular smooth muscle cells (VSMCs) are proposed to
regulate vascular tone andmay be potential targets for
controlling blood pressure [4–6]. However, there is
currently little consensus on the overall function of
CaSR in the vasculature, with studies suggesting that
stimulation of CaSR induces both vasoconstriction
and vasorelaxation through diverse cellular mechan-
isms [4–20]. In the presence of closely regulated
plasma Ca2+ levels, stimulation of CaSR in the vascu-
lature is considered possible as local [Ca2+]o is likely to
rise sufficiently at the surface of cells due to active Ca2+
transport mechanisms such as the Ca2+-ATPase and
the Na+-Ca2+ exchanger [3,11,21].
We have previously shown that stimulation of
CaSR by increasing [Ca2+]o induces an endothelium-
dependent relaxation in rabbit mesenteric arteries,
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which requires stimulation of the nitric oxide (NO)-
guanylyl cyclase (GC)-protein kinase G (PKG)
pathway coupled to activation of large conductance
Ca2+-activated K+ (BKCa) channels in VSMCs, and
activation of intermediate conductance Ca2+-
activated K+ (IKCa) channels inducing endothelium-
derived hyperpolarisations [16]. In a recent
pharmacological study investigating how stimula-
tion of CaSR may induce these mechanisms, we
reported that CaSR-mediated activation of endothe-
lial heteromeric TRPV4/TRPC1 channels is required
for NO production whereas a different cation chan-
nel in ECs is likely to be involved in IKCa channel
activation [20]. These data correspond with increas-
ing evidence that TRPV4 channels have major roles
in regulating vascular tone, including mediating
flow- and agonist-induced vasodilatations via stimu-
lation of NO production, and that TRPV4-mediated
vascular responses are mediated by heteromeric
TRPV4/TRPC1 channel structures expressed in
ECs [23–27]. The present study provides further
evidence for the role of heteromeric TRPV4-
TRPC1 channels in CaSR-induced relaxations
by comparing the effect of stimulating CaSR in
mesenteric arteries from wild-type (WT) and
TRPC1-/- mice. Using wire myography, fluorescent
microscopy, and electrophysiological techniques,
our results suggest that heteromeric TRPV4/
TRPC1 channels mediate CaSR-induced endothe-
lium-dependent relaxations via NO production in
mouse mesenteric arteries, and that TRPV4/TRPC1
channels may be the predominant TRPV4-
containing channels present in mouse mesenteric
artery ECs.
Results
CaSR-induced vasorelaxations and NO
production are reduced in TRPC1-/- mice
We initially investigated if stimulating CaSR by
increasing [Ca2+]o produced similar endothelium-
dependent relaxations of mouse mesenteric arteries
to those described in rabbit mesenteric arteries [16].
In WT vessels, Figure 1(a–e) show that increasing
[Ca2+]o from 1–6 mM produced relaxations of pre-
contracted tone induced by 10 μM methoxamine
which were decreased by pre-treatment with the
CaSR blocker Calhex-231, and were abolished by
removal of a functional endothelium (Figure S2).
Importantly, Figure 1(b–e) show that increasing
[Ca2+]o induced significantly smaller relaxations of
TRPC1-/- vessel segments compared to WT, although
these relaxations were still inhibited by Calhex-231
and removal of a functional endothelium (Table 1). In
control experiments, vasoconstrictions induced by
10 μM methoxamine and 60 mM KCl, and vasore-
laxations induced by the NO donor SNP were similar
in WT and TRPC1-/- vessels (Figure 1(a) and S1),
indicating that the general ability of vessels to contract
and relax was not impaired in the absence of TRPC1.
In our next experiments, we compared the role
of NO in CaSR-induced vasorelaxations and NO
production in WT and TRPC1-/- preparations.
Figure 2(a) shows that pre-treatment with the
endothelial nitric oxide synthase inhibitor
L-NAME (L-NA) inhibited CaSR-induced relaxa-
tions in WT and TRPC1-/- vessels. In addition,
Figure 2(b,c) reveal that increasing [Ca2+]o from
1 mM to 6 mM increased baseline fluorescence of
DAF-FM, a cell-permeable fluorescent NO indica-
tor, by about 30% in WT ECs which was inhibited
by pre-treatment with Calhex-231 and L-NA. In
comparison, Figure 2(b,c) show that in TRPC1-/-
ECs, 6 mM [Ca2+]o induced a smaller 15% increase
in DAF-FM fluorescence, which was also inhibited
by Calhex-231 and L-NA.
These results suggest that stimulation of CaSR
induces endothelium-dependent relaxations invol-
ving NO production in mouse mesenteric arteries,
and that these mechanisms involve TRPC1.
TRPV4 and TRPC1 are both involved in
CaSR-induced vasorelaxations and NO
production
To investigate the role of TRPV4 and TRPC1 chan-
nels in CaSR-induced vasorelaxations and NO pro-
duction, we compared the effects of the TRPV4
blocker RN1734 (RN) and the TRPC1 blocking anti-
body T1E3 in WT and TRPC1-/- mice. Figure 3(a,b)
show that pre-treatment with RN produced
a profound reduction in [Ca2+]o-induced relaxations
of pre-contracted tone in both WT and TRPC1-/-
vessels, whereas pre-treatment with T1E3 only pro-
duced a reduction in [Ca2+]o-induced relaxations in
WT vessels (Table 1). Pre-incubation of T1E3 with
its antigenic peptide prevented the inhibitory effect
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of T1E3 on [Ca2+]o-induced relaxation in WT ves-
sels. In addition, RN inhibited increases in baseline
DAF-AM fluorescence induced by 6 mM [Ca2+]o in
both WT and TRPC1-/- ECs, whereas T1E3 only
reduced increases in [Ca2+]o-induced baseline fluor-
escence in WT ECs.
These results indicate that both TRPV4 and
TRPC1 channels are required for CaSR-induced
relaxations and NO production in mouse mesen-
teric arteries Interestingly, our findings suggest
that CaSR-evoked TRPV4-containing channels
can partially compensate in the absence of TRPC1.
Heteromeric TRPV4-TRPC1 channels are
expressed in mouse mesenteric artery ECs
We next examined the expression of TRPV4 and
TRPC1, and potential heteromeric TRPV4/TRPC1
channel compositions in mesenteric artery ECs in
WT and TRPC1-/- mice. Figure 4(a) shows that
TRPV4 and TRPC1 proteins were expressed in
WT ECs using immunocytochemistry, with stain-
ing and pronounced co-localization present at, or
close to, the plasma membrane. As expected,
Figure 4(a) also reveals that TRPV4 was expressed
at, or close to, the plasma membrane of TRPC1-/-
ECs but contained no detectable TRPC1 staining.
Moreover, Figure 4(b,c) show that TRPV4 and
TRPC1 form puncta signals using proximity liga-
tion assay in WT but not TRPC1-/- ECs indicating
close spatial localization.
TRPV4 and TRPC1 are both involved in
GSK-induced vasorelaxations and cation channel
activity
As the present study indicates that heteromeric
TRPV4/TRPC1 channels mediate CaSR-induced
vasorelaxations and NO production, we pre-
dicted that GSK101970A (GSK), a TRPV4 ago-
nist, would induce vasorelaxations that are
likely to be inhibited by TRPC1 blockade.
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Figure 1. [Ca2+]o-induced relaxations of pre-contracted tone in mesenteric arteries from WT and TRPC1
-/- mice are mediated by
CaSRs and endothelium.
(a) Original traces showing that bath application of methoxamine (MO) induced sustained increases in tension in wild-type (WT) and
TRPC1-/- (C1-/-) vessel segments containing a functionally-intact endothelium. (b) Representative traces showing that increasing [Ca2+]o
from 1–6 mM induced relaxations of pre-contracted tone in both WT and C1-/- vessels which contain a functional endothelium, but that
responses in C1-/- vessels were reduced. (c) Representative traces showing that [Ca2+]o-induced relaxations of pre-contracted tone were
absent in both WT and C1-/- vessels that did not contain a functionally-intact endothelium. (d and e) Mean data showing that [Ca2+]o-
induced relaxations were smaller in C1-/- compared toWT vessels, and that responses in bothWT and C1-/- vessels were reduced by Calhex-
231 and absent following removal of a functional endothelium. Each point is from at least N = 6 animals, with at least n = 3 vessel
segments from each animal. *Compares data to WT control, and #compares data to C1-/- control. One, two, and three symbols denote
p < 0.05, p < 0.01, and p < 0.001 respectively.
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Figure 5(a,b) illustrate that GSK induced pro-
nounced relaxations of pre-contracted tone of
WT and TRPC1-/- mesenteric artery segments,
which were reduced by removal of the endothe-
lium, and by pre-treatment with either
L-NAME or RN. Pre-treatment with T1E3
reduced GSK-induced vasorelaxations in WT
vessels but had no effect on TRPC1-/- vessels.
Interestingly, GSK at high concentrations (e.g.
100 nM) was still able to induce full relaxations
in WT and TRPC1-/- vessels, which were main-
tained following removal of a functional
endothelium (Figure 5 c).
In our final experiments, we investigated the effect
of GSK on cation channel activity at the single chan-
nel level in freshly isolated ECs. Figure 6(a,b) show
that inclusion of 10 nM GSK in the patch pipette
solution evoked cation channel activity in cell-
attached patches from WT ECs, which had current
amplitudes of about −0.5pA at −80 mV. This
corresponded to a unitary conductance of about
6pS (Figure 6c). In contrast, Figure 6(a,b) reveal
that GSK-induced cation channel activity in
TRPC1-/- ECs had current amplitudes of about
−4pA at −80 mV and a unitary conductance of
about 52pS (Figure 6c). Figure 6a also shows that
cation channel activity was not recorded when GSK
was absent from the patch pipette solution. In addi-
tion Figure 6(a,b) demonstrate that the GSK-evoked
52pS channel seen in TRPC1-/- ECswas not observed
in WT ECs.
These results provide further evidence that het-
eromeric TRPV4/TRPC1 contribute to GSK-
induced vasorelaxations in mouse mesenteric
arteries, and that these are the predominant TRPV4-
containing channels inmousemesenteric artery ECs.
In addition, these data indicate that GSK activates
other TRPV4-containing channels which are likely
responsible for CaSR-mediated vasorelaxations and
NO production observed in TRPC1-/- preparations.
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Figure 2. [Ca2+]o-induced relaxations of pre-contracted tone in mesenteric arteries from WT and TRPC1
-/- mice involve nitric oxide
production in endothelial cells.
(a) Mean data showing that [Ca2+]o-mediated relaxations of pre-contracted tone in WT and TRPC1
-/- vessels containing a functional
endothelium were inhibited by pre-treatment with L-NAME (L-NA). Each point is from at least N = 6 animals, with at least n = 3
vessel segments from each animal. (b) Representative images and mean data showing that 6 mM [Ca2+]o induced an increase in
DAF-FM fluorescence in WT and TRPC1-/- ECs, with a smaller response in TRPC1-/- ECs. (c) Mean data showing that pre-treatment with
Calhex-231 and L-NA inhibited increases in DAF-FM fluorescence from WT and TRPC1-/- ECs induced by 6 mM [Ca2+]o. Each
experiment from N = 6 animals, with n>50 cells per animal.
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Discussion
This comparative study using WT and TRPC1-/-
mice shows that stimulating CaSR induces
endothelium-dependent relaxations via NO pro-
duction in mesenteric arteries, which require acti-
vation of heteromeric TRPV4/TRPC1 channels in
ECs. These findings complement our recent study
that proposed a similar role for heteromeric
TRPV4/TRPC1 channels in CaSR-induced vasore-
laxations and NO production in rabbit mesenteric
arteries[20]. In addition, the present study also
provides further evidence that heteromeric
TRPV4/TRPC1 channels may be the predominant
TRPV4-containing channels in ECs[20].
CaSR-induced relaxations and NO production in
mouse mesenteric arteries are mediated by
heteromeric TRPV4/TRPC1 channels
The present study shows that increasing [Ca2+]o
induces vasorelaxation of mesenteric arteries from
WT mice, which are inhibited by the CaSR blocker
Calhex-231. This confirms earlier studies indicating
that stimulation of CaSR by increasing [Ca2+]o
induces relaxations in mouse mesenteric arteries
[14,18], and also in rat and rabbit mesenteric arteries
[10,16,17,20,28]. In addition, our results from WT
mice illustrate that CaSR-induced vasorelaxations
require an endothelium-dependent pathway invol-
ving endothelial nitric oxide synthase, and that
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Figure 3. Effect of TRPV4 and TRPC1 channel blockers on [Ca2+]o-induced relaxations and nitric oxide production from WT and
TRPC1-/- mice.
(a) Mean data showing that pre-treatment with RN1734 (RN) reduced [Ca2+]o-induced relaxations of pre-contracted tone in both WT
and C1-/- vessels, whereas T1E3 only attenuated [Ca2+]o-induced relaxations in C1
-/- vessels. Note that pre-incubation of T1E3 with its
antigenic peptide (AgP) prevented the action of T1E3 on [Ca2+]o-induced relaxations in WT vessels. Each point from at least N = 6
animals, and at least n = 3 vessel segments per animal. (b) Mean data showing that RN reduced DAF-FM fluorescence induced by
6 mM [Ca2+]o in WT and TRPC1
-/- ECs, whereas T1E3 only reduced responses in WT ECs. Each experiment from n = 6 animals, with
n > 50 cells per animal.
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stimulation of CaSR activates NO production in ECs.
These findings confirm earlier studies in rabbit
mesenteric arteries [16,20], but are different to stu-
dies using rat mesenteric arteries where an endothe-
lium-independent role for perivascular nerves and
cytochrome P450 metabolites is reported [7,8,10]. In
conclusion, it seems clear that the predominant
action of stimulating CaSR in mesenteric arteries is
relaxation, although the pathways involved may be
species-dependent.
The main aim of this study was to investigate an
earlier proposal that heteromeric TRPV4/TRPC1
channels in ECs mediate CaSR-induced vasore-
laxations and NO production in mesenteric
arteries by comparing effects from WT and
TRPC1-/- mice. In WT mice, CaSR-induced vasor-
elaxations and NO generation in ECs were inhib-
ited by RN and T1E3, and co-localization of
TRPV4 and TRPC1 staining were present using
immunocytochemical and PLA staining. In con-
trast, in TRPC1-/- mice preparations, CaSR-
induced vasorelaxations and NO production in
ECs were reduced by about 50% compared to
WT and not affected by T1E3, with the remaining
responses inhibited by RN. These results collabo-
rate with our previous findings in rabbit mesen-
teric arteries [16,20] to further indicate that
endothelial CaSR-mediated pathways predomi-
nantly involve TRPV4/TRPC1-mediated Ca2+
influx and subsequent Ca2+-CaM-eNOS activity
to induce the classical NO-GC-PKG pathway in
the regulation of vascular tone.
The findings of the current study also support
earlier studies indicating that heteromeric TRPV4/
TRPC1 channels are expressed in ECs, which may
also involve TRPP2 subunits [21, 23–27] making
this channel unique by being composed of subu-
nits from three different TRP subfamilies.
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Figure 4. Expression and co-localization of heteromeric TRPV4-TRPC1 channels in mesenteric artery ECs.
(a) Representative immunocytochemical images of TRPV4 (red) and TRPC1 (green) channel proteins in WT and TRPC1-/- ECs, showing
expression and co-localization (yellow) at, or close to, the plasma membrane. (b) Representative images and (c) mean data from PLA
studies illustrating TRPV4 and TRPC1 co-localization puncta staining (red) in WT ECs, but not in TRPC1-/- ECs. Data is from n = 4
animals, >10 cells per animal to calculate average number of puncta per cell.
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Several studies show that TRPC1-containing chan-
nels, including heteromeric TRPV4/TRPC1 channels
in ECs, act as store-operated channels with TRPC1
likely to confer the ability of channels to be activated
by store depletion via STIM1-mediated mechanisms
in different cell types [21, 29–35]. Therefore, wemight
hypothesize that for optimal CaSR-induced vasore-
laxations and NO generation to occur in WT mice
and rabbit preparations, heteromeric TRPV4/TRPC1
channels are activated by store depletion-mediated
pathways, but that different CaSR-mediated activa-
tion pathways of other TRPV4-containing channels
are also present. This may explain how remaining
TRPV4-containing channels mediating CaSR-
induced vasorelaxations and NO production are able
to partially compensate in TRPC1-/- mice. In support
of this hypothesis, a previous report showed that
CCh-induced relaxation and NO production in
aorta are reduced but not abolished in TRPC1-/-
mice[36]. In future studies, it will be therefore be
important to determine if CaSR-induced heteromeric
TRPV4/TRPC1 channel activation involves receptor
stimulation via store depletion.
GSK-evoked vasorelaxations are mediated by
different TRPV4-containing channels in WT and
TRPC1-/- ECs
In rather surprising results, the concentration-
response curves of GSK-induced relaxations were
similar in mesenteric arteries from WT and
TRPC1-/- mice, and were inhibited to a similar
extent by RN, L-NA, and removal of a functional
endothelium whereas T1E3 only inhibited
responses in WT mice. This suggests that GSK-
activated heteromeric TRPV4/TRPC1 channels in
WT and distinct TRPV4-containing channels in
TRPC1-/- mice via pathways that were equally
potent at inducing vasorelaxations. Consistent
with this conclusion, GSK activated a 6 pS cation
channel in WT ECs and a 52 pS channel in
TRPC1-/- ECs which are likely to represent distinct
TRPV4-containing channels. In our recent study
in rabbit mesenteric artery ECs, GSK also activated
a 6 pS cation channel which was inhibited by RN
and T1E3 suggesting that this represented
a channel composed of TRPV4 and TRPC1 sub-
units[20].
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Figure 5. Effect of GSK1016790A on pre-contracted tone and NO production in WT and TRPC1-/- mice.
(a) Original traces and mean data showing that GSK1016790A (GSK)-induced relaxations of pre-contracted tone were similar in WT
and C1-/- vessels. WT EC50 was 4.6 ± 0.2nM vs. 4.9 ± 0.3nM in C1
-/- vessels whilst WT Emax was 98.9 ± 4.3% vs. 101.5 ± 5.4% in C1
-/-
vessels. (b) Mean data showing that GSK-induced relaxations of pre-contracted tone were inhibited by RN1734 (RN) at all
concentrations of GSK tested in WT and TRPC1-/- vessels. In contrast, removal of a functional endothelium and pre-treatment
with L-NA only inhibited responses induced by <100 nM GSK, and T1E3 only had an inhibitory action in WT compared to TRPC1-/-
vessels. Data from at least N = 6 animals, with at least n = 3 segments from each animal.
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Notably, the current study did not reveal any
obvious pharmacological differences between het-
eromeric TRPV4/TRPC1 channels in WT mice
compared with TRPV4-containing channels in
TRPC1-/- mice. GSK was equally potent at inducing
vasorelaxations of WT compared with TRPC1-/-
vessels and GSK-evoked NO-mediated responses
were also equally sensitive to L-NA and to
RN1734. Given that TRPV4 heteromisation with
TRPC1 might be expected to determine distinct
pharmacological features compared with TRPV4-
containing channels in which TRPC1 is absent, in
future studies it will be important to examine for
potential pharmacological differences in greater
detail e.g. by using different concentrations of
RN1734 to inhibit channel activity, or by utilizing
a range of other TRPV4 channel modulators not
used in the current study – e.g. 4αPDD and
HC067047.
Interestingly, high concentrations of GSK (e.g.
100 nM) were able to induce full vasorelaxations in
WT and TRPC1-/- mice in the presence of L-NA,
T1E3, and removal of a functional endothelium.
This suggests that either high concentration of
GSK can overcome these inhibitory actions, e.g.
there is enough functional endothelium remaining
to induce relaxations, or that at high concentra-
tions GSK may activate TRPV4-containing chan-
nels expressed on VSM to induce relaxations as
had previously been reported[37].
Over-expression of TRPV4 and TRPC1 subunits
and TRPV4-TRPC1 concatamers in HEK293 cells
produced 4αPDD-evoked inward single channel
activity with a unitary conductance of about 80pS
[25], which is obviously very different to the 6pS
channel conductance we recorded in WT ECs but
similar to the 52pS channels in TRPC1-/- ECs. These
observations were surprising and the precise
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Figure 6. GSK1016790A-evoked cation channel currents in WT and TRPC1-/- ECs.
(a) Application of GSK1016790A (GSK) in the patch pipette solution activated cation channel activity in cell-attached patches held at
−80 mV from WT and TRPC1-/- ECs, with single channel current amplitudes being much greater in TRPC1-/- ECs. (b) Representative
amplitude histograms of GSK-induced single channel activity from WT and TRPC1-/- ECs. Amplitude histograms had 3 identifiable
peaks representing one closed (0 pA) and two unitary amplitude levels, namely ~-0.5 pA and −1pA in the WT patch vs. ~- 4pA and
−8pA in the TRPC1-/- EC patch. Given these values are multiples of each other it is likely that the respective patches contained at
least 2 channels. (c) Mean pooled current/voltage relationships of GSK-evoked cation channel activities in WT and TRPC1-/- ECs,
which had unitary conductances of 5.8pS and 52.2pS respectively, and similar extrapolated reversal potentials of about 0 mV. Each
data set is from at least n = 6 patches, from at least N = 5 animals, ***p < 0.001, 2-way ANOVA.
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explanation for these differences remains unclear. It
is possible that the electrophysiological properties of
these channels are different in over-expression sys-
tems compared to native cells present in their phy-
siological environment, or that the low 6pS
conductance also reflects the presence of TRPP2 in
the composition of the native channel. It will be
important to investigate these differences in the
future.
Are heteromeric TRPV4-TRPC1 channels the
predominant native TRPV4-containing channels
in mesenteric artery ECs?
The present work only observed a 6pS channel
composed on TRPV4 and TRPC1 subunits in
WT ECs, which indicate that heteromeric
TRPV4/TRPC1 channels are the predominant
native TRPV4-containing channels in these cells.
However, the TRPC1 blocker T1E3 was not as
effective in reducing CaSR-induced vasorelaxa-
tions and NO production compared to RN1734
in preparations from WT mice, which may suggest
that either other TRPV4-containing channels are
present in WT ECs or that the T1E3 blocking
antibody is less potent than a small molecular
weight inhibitor. If other TRPV4-containing chan-
nels are present in WT ECs they are likely to be
functionally expressed at low levels.
Sonkusare et al proposed that GSKapplication
activated large amplitude Ca2+ sparklets, mediated
by Ca2+ influx through a small number of rarely-
opening TRPV4-containing channels that formed
a cooperative cluster of about 4 channels. This in
turn produces endothelium-dependent vasore-
laxation via stimulation of SKCa and IKCa channels
but not NO production in pressurized third-order
mouse mesenteric arteries[38]. In contrast, the
present work shows that GSK-induced vasorelaxa-
tion is mediated by NO generation in first-order
mouse mesenteric arteries using wire myography.
These disparities may represent differences
between species, pressurized vessels and wire
myography, vessel order, and activation of hetero-
meric TRPV4/TRPC1 6pS channels versus other
TRPV4-containing channels, e.g. perhaps the 52pS
channel. It would be interesting to investigate if
the GSK-activated 6pS TRPV4/TRPC1 channels
observed in rabbit mesenteric artery ECs could
support enough Ca2+ entry to mediate Ca2+ spark-
lets, and if TRPC1 is involved in GSK-mediated
Ca2+ sparklets and vasorelaxations in recorded in
third-order mouse mesenteric artery ECs.
Conclusion
This comparative study using WT and TRPC1-/-
mice provides further evidence that heteromeric
TRPV4/TRPC1 channels are involved in CaSR-
induced vasorelaxations through NO production
in mesenteric arteries. These findings consolidate
the proposals that vascular CaSR and heteromeric
TRPV4/TRPC1 channels may represent novel
therapeutic targets for regulating vascular tone
and treating cardiovascular disease.
Materials and methods
Reagents
Goat anti-TRPV4 antibody (sc-47,527) characterized
in several previous studies [27,39–41] was obtained
from Santa Cruz Biotechnology (Dallas, Tx, USA) and
T1E3, a rabbit anti-TRPC1 antibody, was generated by
GenScript (Piscataway, NJ, USA) using a peptide
sequence from a characterized putative extracellular
pore region of the TRPC1 subunit[42]. Alexa Fluor
546-conjugated donkey anti-goat antibody (1:500)
and Alexa Fluor 488-conjugated donkey anti-rabbit
antibodies were obtained from Thermo Fisher
Scientific (Walham, MA, USA). All drugs were pur-
chased from Sigma-Aldrich (Sigma Chemical Co.,
Poole, UK) or Tocris (Tocris Biosciences, Bristol,
UK). Drugs were dissolved in distilled water or
dimethyl sulfoxide (DMSO).
Animals
Wild-Type (WT) and TRPC1-/− mice[43] aged
12–16 weeks and weighing 30–40 g, were used in
this study. The initial mouse breeding colony was
provided by the Comaprative Medicine Branch of
the NIEHS (National Institute of Environmental
Health Sciences, USA). The mice were housed in
the Biological Research Facility (BRF) at St
George’s University of London according to the
requirements of the Code of Practice for animal
husbandry, Animals Scientific Procedures Act
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1986, amended in 2012. Animals were group-
housed within appropriately sized single cages
and room environmental conditions were con-
trolled by an automated building management
system that maintained a Light:Dark cycle of
12:12 hr, a room ambient temperature within
a range of 18–22ºC, and a relative humidity of
50 ± 10%. They received ad lib fresh water and
laboratory rodent diet (SDS, UK) and were pro-
vided with various environmental stimuli. All mice
were killed by cervical dislocation, in accordance
with Schedule I of the UK Animals Scientific
Procedures Act, 1986 and St George’s University
of London Animal Welfare and Ethical Review
Committee.
Cell and vessel segment preparation
First-order branches of the mouse superior mesen-
teric artery were micro-dissected and cleaned of
adherent connective tissue and perivascular fat in
physiological salt solution (PSS) containing (mM):
NaCl 126, KCl 6, Glucose 10, HEPES 11, MgCl2 1.2,
and CaCl2 1.5, pH adjusted to 7.2 with 10M NaOH.
Mean resting vessel diameters in WT vs. TRPC1-/−
were similar (195 ± 6.3 vs. 197 ± 5.4 µm, n = 18
animals, >40 vessels per group)
Isolated vessels were then cut into 2 mm seg-
ments for wire myography experiments or first
order and were dispersed to obtain freshly iso-
lated ECs as previously described [16,20]. For EC
isolation, vessels were washed in PSS containing
50 µM [Ca2+]o for 5 min at 37°C and placed in
collagenase solution (1 mg.ml-1) for 14 min at
37°C. Vessels were then triturated in fresh 50 µM
[Ca2+]o PSS and the cell-containing solution was
collected and centrifuged for 1 min at 1000 rpm.
The supernatant was removed and the cells re-
suspended in fresh 0.75 mM [Ca2+]o PSS, before
plating onto coverslips. Isolated cells were then
left at 4°C for 1 hr before use. Freshly isolated
ECs were identified by their classic “cobblestone”
morphology and “sheet-like” appearance[44].
Immunocytochemistry
Freshly isolated mouse mesenteric artery ECs
were fixed onto borosilicate coverslips with ice-
cold 4% paraformaldehyde (Sigma-Aldrich,
Gillingham, UK) for 10 min, washed 4 times
with ice-cold phosphate-buffered saline (PBS),
and permeabilised with PBS containing 0.1%
Triton X-100 for 20 min at room temperature.
Cells were then washed 4 times with ice-cold PBS
and incubated with PBS containing 1% bovine
serum albumin (BSA) for 1 hr at room tempera-
ture to block nonspecific antibody binding. The
cells were then incubated overnight at 4°C with
a TRPV4 antibody and T1E3. In control experi-
ments, cells were incubated without primary
antibodies. The following day, cells were washed
4 times with ice-cold PBS and incubated with
secondary antibodies conjugated to fluorescent
probes, Alexa Fluor 546-conjugated donkey anti-
goat antibody or Alexa Fluor 488-conjugated
donkey anti-rabbit antibodies (1:500). Unbound
secondary antibodies were removed by washing
with ice-cold PBS 4 times, and nuclei were
labeled with 4ʹ,6-diamidino-2-phenylindole
(DAPI) mounting medium (Sigma-Aldrich).
Cells were imaged using a Zeiss LSM 510 laser
scanning confocal microscope (Carl Zeiss, Jena,
Germany). Excitation was produced by stimula-
tion with 543 nm or 488 nm lasers where appro-
priate, delivered to the specimen via a Zeiss
Apochromat x63 oil-immersion objective.
Emitted fluorescence was captured using LSM
510 software (release 3.2; Carl Zeiss). Two-
dimensional images cut horizontally through the
middle of the cells were captured and raw confocal
imaging data processed using Zeiss LSM 510 soft-
ware. Final images were produced using
PowerPoint (Microsoft XP; Microsoft, Richmond,
WA, USA).
Proximity ligation assay
PLA[45] was performed using the Duolink in situ
PLA detection kit 563 (Olink, Uppsala, Sweden)
according to the manufacturer’s instructions.
Freshly isolated mouse mesenteric artery ECs were
fixed onto borosilicate coverslips with ice-cold 4%
paraformaldehyde (Sigma-Aldrich, Gillingham,
UK) for 10 min and then permeabilised in PBS
containing 0.1% Triton X-100 for 20 min. ECs
were blocked for 1 hr at 37°C using Duolink block-
ing solution to reduce nonspecific binding and were
incubated overnight at 4°C with a TRPV4 antibody
10 H. Z. E. GREENBERG ET AL.
and T1E3 (both at dilution 1:200) in Duolink anti-
body diluent solution. Control experiments were
carried out by omitting the primary antibodies.
Secondary anti-goat PLUS and anti-rabbit MINUS
antibody probes were then added for 1 hr at 37ºC.
These specialized secondary antibodies with oligo-
nucleotides attached, hybridize with additional oli-
gonucleotides when in close proximity (<40 nm).
Hybridized oligonucleotides were then ligated for
30 min at 37°C to form a closed DNA circle, before
a rolling circle amplification step was initiated, last-
ing 100 min at 37°C. Complimentary oligonucleo-
tides with a red fluorescence label attached were
then hybridized to the products of the rolling circle
amplification step and visualized as red puncta
using a confocal LSM 510 microscope (Carl Zeiss).
Mid-cell sections were selected, and the number of
puncta were counted manually.
Isometric tension recordings
Vessel segments 2 mm in length were mounted in
a wire myograph (Model 610 M; Danish Myo
Technology, Aarhus, Denmark) and equilibrated
for 30 min at 37°C in 5 ml of gassed (95% O2/5%
CO2) Krebs–Henseleit solution, composed of
(mM): NaCl 118, KCl 4.7, MgSO4 1.2, KH2PO4 1.2,
NaHCO3 25, CaCl2 2, D-glucose 10, pH 7.2. Vessels
were normalized to 90% of the internal circumfer-
ence predicted to occur under a transmural pres-
sure of 100 mmHg[46]. After normalization, vessels
were left for 10 min and were then challenged with
60 mM KCl for 5 min. Following a wash out with
fresh Krebs solution, endothelium integrity was
assessed by stably pre-contracting vessels with
10 µM methoxamine followed by the addition of
10 µM carbachol (CCh). Vessels in which CCh-
induced vasorelaxations were >80% of pre-
contracted tone were designated as having
a functional endothelium intact. When required,
endothelium was removed by rubbing the intima
with a human hair. CCh-induced vasorelaxations of
<10% of pre-contracted tone indicated successful
removal. Vessel segments were then incubated for
30 min in fresh Krebs solution containing 1 mM
CaCl2 followed by pre-contraction with 10 µM
methoxamine. This was followed by cumulative
additions of CaCl2 to increase [Ca
2+]o between
1–6 mM and thereby stimulate CaSR, or by
cumulative additions of the selective TRPV4 ago-
nist GSK1016790A (1–100 nM) in the presence of
inhibitors tested or their respective vehicles. All
inhibitors or their respective vehicles were added
to the vessels 30 min before the construction of the
concentration-response curves to [Ca2+]o or
GSK1016790A. For each experiment, vehicle con-
trols were performed using vessel segments from
the same animal.
NO imaging
Experiments to visualize the production of NO in
freshly isolated ECs were performed using the
well-established cell-permeable fluorescent NO
indicator DAF-FM diacetate [47,48]. Freshly dis-
persed ECs were placed in a sterilized 96-well
plate and left for 1 hr at 4°C. Following this, ECs
were loaded with 1 µM DAF-FM diacetate, incu-
bated at 4°C for 20 min, and then washed with
fresh PSS containing 1 mM [Ca2+]o. The cells were
left for another 30 min at 4°C to allow complete
de-esterification of intracellular diacetate.
Inhibitors tested, or their respective vehicles
were also added at this point. Changes in fluores-
cence following 5 min of CaSR stimulation with
6 mM [Ca2+]o were captured using a Zeiss
Axiovert 200M Inverted microscope. All experi-
ments were performed at room temperature. The
captured images were then processed and ana-
lyzed using AxioVision SE64 Software (Rel. 4.9.1;
Carl Zeiss).
Electrophysiology
Freshly isolated mouse mesenteric artery ECs
from WT and TRPC1-/- animals were used for
recording single cation channel currents. Single
channel activity was measured using the cell-
attached configuration of the patch-clamp tech-
nique and recorded using an Axopatch 200B
amplifier (Axon Instruments, Union City, CA,
USA). Single cation channel currents were fil-
tered at 100 Hz (−3 dB, low-pass 8-pole Bessel
filter, Frequency Devices model LP02; Scensys,
Aylesbury, UK) and sampled at 1 kHz (Digidata
1322A and pCLAMP 9.0 software; Molecular
Devices, Sunnydale, CA, USA). All recordings
were made in voltage-clamp mode at a holding
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potential of −40 mV and current/voltage (I/V)
relationships were then evaluated by altering the
holding potential between −80 and +80 mV.
The external bathing solution for cell-attached
patch recordings contained in mM: 126 KCl, 1
CaCl2, 10 HEPES, and 11 glucose, adjusted to pH
7.2 with 10M KOH. The patch pipette solution con-
tained (mM): 126 NaCl, 1 CaCl2, 10 HEPES, and 11
glucose adjusted to pH 7.2 with 10M NaOH. 100 μM
DIDS, 100 μM niflumic acid, 10 mM TEA, 100 nM
Apamin, and 100 nM CbTX were also included into
block Ca2+ and swell-activated Cl- conductances,
voltage-gated K+ channels, and SKCa, IKCa, and
BKCa channels respectively. This enabled cation con-
ductances to be recorded in isolation. Single cation
channel currents were activated by including 10 nM
GSK1016790A in the patch pipette solution. All
recordings took place at room temperature.
Data and statistical analysis
Data points presented on all graphs and bar charts
are mean values ± SEM, P < 0.05 was considered
a significant difference between groups. For wire
myography experiments, all relaxant responses are
expressed as percentage relaxation of stable precon-
tracted tone induced by 10 µM methoxamine.
Responses to increasing concentrations of [Ca2+]o
and GSK101790A in treated vs. control vessels for
both wild-type and TRPC1-/- mice were analyzed by
2-way ANOVA followed by Bonferroni post hoc
tests. Bonferroni comparisons are shown above the
graph data points whereby: * P < 0.05, ** P < 0.01, ***
P < 0.001, **** P < 0.0001 vs. control. Statistical
analysis and graphs were made using Graphpad
Prism 6 software (GraphPad Software, Inc, San
Diego, CA, USA).
For NO imaging experiments, changes in DAF-
FM fluorescence before and after CaSR stimulation
were quantified by selecting a cell as a region of
interest (ROI). Changes in fluorescence levels within
the ROI before and after the experimental protocols
were analyzed using unpaired Student’s t-test. Figures
and analysis were made using Graphpad Prism 6
(GraphPad Software, Inc, San Diego, CA, USA).
For analysis of single-channel recordings, current
amplitudes were calculated from traces of ≥ 60 s in
duration using the 50% threshold method.
Amplitude histograms were fitted with gaussian
curves using a bin width of 0.01pA and 0.05pA for
WT and TRPC1-/- patches respectively, with peak
values corresponding to channel open levels. Mean
channel amplitudes at respective membrane poten-
tials between −80 and +80mVwere plotted, enabling
current/voltage (I/V) relationships to be fitted by
linear regression, with the gradient determining con-
ductance values. Figures and analyses were prepared
using MicroCal Origin 6.0 software (MicroCal
Software, Northampton, MA, USA), in which
inward single-channel openings are shown as down-
ward deflections. *P < 0.05, **P < 0.01, ***P < 0.001,
****P < 0.0001 vs. relevant controls.
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